Logistics in any entity takes care of acquirement, devising, and executing processes in the transit of goods from one locality to another. Factors like control of temperature, compliance with the government regulations, security, safety and custody chain are the focus areas of biopharmaceutical companies that have to be handled in different stages of production. The strategic supply chain management offers the solution for those manufacturers. Logistics, being an integral part of organizations, is used by the pharmaceutical companies to manage and control the distribution of healthcare products and medical devices to various customers as per their requirement. Thus, the logistics benefit the pharmaceutical industry to regularly supply medicines, devices and other equipment to agents and distributors located in different places.
Outsourcing logistics services to external companies called as Logistics Service Providers (LSP) in recent years are helping the pharmaceutical companies to concentrate more on improving their marketing, sales, research and development, and other core areas. The outsourcing logistics services implemented by many companies as a part of their business strategy are also helping in improving the cost-efficiency by eliminating the additional expenses.
The global bio-pharmaceutical logistics market recorded net worth of USD62.0 billion in 2016 and with an increasing CAGR of 7.0% in the forecast period between 2017e and 2024f, is expected to cross USD100 billion by 2024f.
The sales of prescription medicines across the world has almost increased by two times in the previous decade and are predicted to cross one trillion by 2020. The expiry of patents for several drugs in the upcoming years will change the preference from actual drug companies to generic medicine manufacturers. The pharmaceutical industry is also having a great impact on production facilities and sales based on the geographic conditions like many other industries. Countries like Asia, Latin America, Middle East, China, etc. are offering more benefits for the pharmaceutical companies, but have to focus on the supply chain regulations of these regions.
Based on geographical distribution, Americas region is comprised of North America and Latin America. The United States of North America holds the largest share of this region’s biopharmaceutical logistics followed by Canada. Latin America with the countries of Brazil, Argentina, Mexico and Rest of Latin America is also increasing the adoption of biopharmaceutical logistics.
The report delivers a strategic analysis of the global biopharmaceutical logistics market and growth forecast for the period from 2017e – 2024f. The scope of the report includes segmental analysis based on type of transport used, and also based on type of product. It also covers geographical analysis of the market with growth forecast for the period of 2017e – 2024f. The geographic analysis section covers market for North America, Europe, Asia-Pacific and Rest of the World. The Porter’s Five Forces analysis also included in the report provides an insight into market dynamics and industry competition.
Moreover, the report also includes growth strategies and entry barriers to be considered to cater to the exact business opportunities in this market. Additionally, to aid in strategic decision making, the report also includes competitive profiling of leading players, recent developments in the industry and various business strategies adopted by them. This report will help players in global pharmaceutical logistics market to plan and implement their strategies in different market areas such as emerging geographies, and new technologies.
The company profile section includes detailed analysis of some of the key players such as Deutsche Post DHL Group, FedEx Corporation, Panalpina World Transport Ltd., and United Parcel Services, Inc.,
Independent Research Consultant
Market Reports Web